A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Development of a biomarker mortality risk model in acute respiratory distress syndrome
2019
Critical Care
Preserved Fulltext
There is a compelling unmet medical need for biomarker-based models to risk-stratify patients with acute respiratory distress syndrome. Effective stratification would optimize participant selection for clinical trial enrollment by focusing on those most likely to benefit from new interventions. Our objective was to develop a prognostic, biomarker-based model for predicting mortality in adult patients with acute respiratory distress syndrome.
doi:10.1186/s13054-019-2697-x
pmid:31842964
fatcat:3zu2dh43fvat3fdxddtasss4ny